PUBLISHER: Grand View Research | PRODUCT CODE: 2132304
PUBLISHER: Grand View Research | PRODUCT CODE: 2132304
The global embolization particle market size was valued at USD 368.9 million in 2025 and is projected to grow from USD 394.6 million in 2026 to USD 661.8 million by 2033, growing at a CAGR of 7.7% from 2026 to 2033. North America dominated the market with the largest revenue share of 36.2% in 2025. The market encompasses minimally invasive embolic technologies used to selectively occlude blood vessels and control, reduce, or redirect blood flow during image-guided procedures.
These technologies are utilized across interventional radiology, oncology, gynecology, and vascular care, particularly for the management of hypervascular tumors, uterine fibroids, arteriovenous malformations, and selected cases of hemorrhage and peripheral vascular conditions. Market development is supported by the growing adoption of image-guided interventions as alternatives or adjuncts to open surgery, the expansion of interventional radiology services, the increasing availability of advanced catheter-based procedures, and a greater emphasis on targeted treatment with reduced procedural morbidity.
Global Embolization Particle Market Report Segmentation
This report forecasts revenue growth at the regional and country levels and provides an analysis of the latest industry trends across each sub-segment from 2021 to 2033. For this study, Grand View Research has segmented the global embolization particle market report based on structure, function, material, particle size, delivery format, application, end use, and region: